GE Healthcare Technologies Inc
NASDAQ:GEHC
GE Healthcare Technologies Inc
NASDAQ:GEHC
Price:
69.23
USD
-3.23%
Market Closed
Market Cap:
$31.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
US |
|
M
|
Mars Group Holdings Corp
TSE:6419
|
JP |
Income Statement
Earnings Waterfall
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc
Income Statement
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc
Currency: USD
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
28
|
20
|
77
|
209
|
334
|
470
|
542
|
528
|
522
|
514
|
504
|
492
|
474
|
455
|
440
|
|
| Revenue |
17 720
N/A
|
17 992
+2%
|
18 341
+2%
|
23 048
+26%
|
19 038
-17%
|
19 284
+1%
|
19 552
+1%
|
19 495
0%
|
19 517
+0%
|
19 558
+0%
|
19 672
+1%
|
19 798
+1%
|
19 966
+1%
|
20 246
+1%
|
20 625
+2%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(10 618)
|
(10 883)
|
(11 162)
|
(13 978)
|
(11 502)
|
(11 586)
|
(11 630)
|
(11 563)
|
(11 523)
|
(11 474)
|
(11 467)
|
(11 484)
|
(11 670)
|
(11 986)
|
(12 378)
|
|
| Gross Profit |
7 102
N/A
|
7 109
+0%
|
7 179
+1%
|
9 070
+26%
|
7 536
-17%
|
7 698
+2%
|
7 922
+3%
|
7 932
+0%
|
7 994
+1%
|
8 084
+1%
|
8 205
+1%
|
8 314
+1%
|
8 296
0%
|
8 260
0%
|
8 247
0%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(4 583)
|
(4 637)
|
(4 657)
|
(5 989)
|
(5 025)
|
(5 175)
|
(5 487)
|
(5 516)
|
(5 540)
|
(5 571)
|
(5 580)
|
(5 600)
|
(5 536)
|
(5 523)
|
(5 484)
|
|
| Selling, General & Administrative |
(3 663)
|
(3 657)
|
(3 631)
|
(4 693)
|
(3 926)
|
(4 014)
|
(4 282)
|
(4 258)
|
(4 253)
|
(4 291)
|
(4 269)
|
(4 271)
|
(4 233)
|
(4 244)
|
(4 225)
|
|
| Research & Development |
(920)
|
(980)
|
(1 026)
|
(1 296)
|
(1 099)
|
(1 161)
|
(1 205)
|
(1 259)
|
(1 288)
|
(1 282)
|
(1 311)
|
(1 331)
|
(1 306)
|
(1 282)
|
(1 260)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
2
|
3
|
3
|
1
|
|
| Operating Income |
2 519
N/A
|
2 472
-2%
|
2 522
+2%
|
3 081
+22%
|
2 511
-19%
|
2 523
+0%
|
2 435
-3%
|
2 416
-1%
|
2 454
+2%
|
2 513
+2%
|
2 625
+4%
|
2 714
+3%
|
2 760
+2%
|
2 737
-1%
|
2 763
+1%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(32)
|
(24)
|
(73)
|
(196)
|
(312)
|
(442)
|
(505)
|
(523)
|
(520)
|
(511)
|
(497)
|
(371)
|
(348)
|
(324)
|
(299)
|
|
| Total Other Income |
116
|
101
|
63
|
173
|
257
|
389
|
431
|
434
|
401
|
355
|
453
|
419
|
385
|
369
|
304
|
|
| Pre-Tax Income |
2 603
N/A
|
2 549
-2%
|
2 512
-1%
|
3 058
+22%
|
2 456
-20%
|
2 470
+1%
|
2 361
-4%
|
2 327
-1%
|
2 335
+0%
|
2 357
+1%
|
2 581
+10%
|
2 762
+7%
|
2 797
+1%
|
2 782
-1%
|
2 768
-1%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(623)
|
(591)
|
(563)
|
(726)
|
(579)
|
(701)
|
(743)
|
(704)
|
(710)
|
(628)
|
(531)
|
(511)
|
(481)
|
(492)
|
(614)
|
|
| Income from Continuing Operations |
1 980
|
1 958
|
1 949
|
2 332
|
1 877
|
1 769
|
1 618
|
1 623
|
1 625
|
1 729
|
2 050
|
2 251
|
2 316
|
2 290
|
2 154
|
|
| Income to Minority Interest |
(51)
|
(44)
|
(51)
|
(62)
|
(51)
|
(52)
|
(46)
|
(49)
|
(41)
|
(53)
|
(57)
|
(67)
|
(74)
|
(73)
|
(70)
|
|
| Net Income (Common) |
1 952
N/A
|
1 926
-1%
|
1 916
-1%
|
2 105
+10%
|
1 649
-22%
|
1 536
-7%
|
1 385
-10%
|
1 570
+13%
|
1 580
+1%
|
1 675
+6%
|
1 993
+19%
|
2 183
+10%
|
2 241
+3%
|
2 217
-1%
|
2 084
-6%
|
|
| EPS (Diluted) |
4.29
N/A
|
4.23
-1%
|
4.22
0%
|
4.62
+9%
|
3.62
-22%
|
3.37
-7%
|
3.03
-10%
|
3.43
+13%
|
3.45
+1%
|
3.65
+6%
|
4.34
+19%
|
4.76
+10%
|
4.88
+3%
|
4.84
-1%
|
4.55
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
